Nano-X Imaging Ltd.
NNOXNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for NNOX. That does not mean none is planned.
Get an email about NNOX's next catalysts
Track Nano-X Imaging (NNOX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
2 upcoming events in our data (earnings, company event).See the timeline
2 upcoming, 1 past
NNOX Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | FQ end Sep/2026 | Call: tbd
Other
Nano-X Imaging postponed its special general meeting of shareholders from November 18 to November 25, 2026, following a board nomination agreement with shareholder Moshe Moalem. The agreement revises the authorized share capital increase in Proposal 1 and adds a new Proposal 3 on a Chairman article amendment.
SourceMarket Overview
Stock performance and key metrics
No drugs found in this phase.
Frequently asked questions
When is Nano-X Imaging Ltd.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Nano-X Imaging Ltd. (NNOX) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track NNOX biotech catalysts?β
Add NNOX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Nano-X Imaging Ltd.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
